These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia. Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258 [TBL] [Abstract][Full Text] [Related]
8. Clinical forms of severe tardive dyskinesia. Gardos G; Cole JO; Salomon M; Schniebolk S Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062 [TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
11. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia]. Chorfi M; Moussaoui D Encephale; 1985; 11(6):263-5. PubMed ID: 2869939 [TBL] [Abstract][Full Text] [Related]
12. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol. Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983 [TBL] [Abstract][Full Text] [Related]
13. The impact of olanzapine on tardive dyskinetic symptoms in a state hospital population. Brar JS; Parepally H; Chalasani L; Gopalani A; Appel N; Chengappa KN Ann Clin Psychiatry; 2008; 20(3):139-44. PubMed ID: 18633740 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder. Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342 [TBL] [Abstract][Full Text] [Related]
15. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253 [TBL] [Abstract][Full Text] [Related]
16. Meclofenoxate therapy in tardive dyskinesia: a preliminary report. Izumi K; Tominaga H; Koja T; Nomoto M; Shimizu T; Sonoda H; Imamura K; Igata A; Fukuda T Biol Psychiatry; 1986 Feb; 21(2):151-60. PubMed ID: 2868761 [TBL] [Abstract][Full Text] [Related]
17. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184 [TBL] [Abstract][Full Text] [Related]
18. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education. Chaplin R; Timehin C Aust N Z J Psychiatry; 2002 Feb; 36(1):99-103. PubMed ID: 11929445 [TBL] [Abstract][Full Text] [Related]
19. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs]. Seigneurie AS; Sauvanaud F; Limosin F Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134 [TBL] [Abstract][Full Text] [Related]
20. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]